Cancer Study Insights
The discussion highlights the complexities of measuring response rates in cancer studies, emphasizing the rigorous protocols followed across multiple centers globally. A complete response, where all signs of cancer vanish, is rare, making partial responses a more common focus. The timeline of enrollment and the role of drug companies and clinical research organizations are also explored, providing a deeper understanding of the trial process.In this clip
From this podcast
Huberman Lab
Journal Club with Dr. Peter Attia | Effects of Light & Dark on Mental Health & Treatments for Cancer
Related Questions